Correlation Between Sangamo Therapeutics and VectivBio Holding
Can any of the company-specific risk be diversified away by investing in both Sangamo Therapeutics and VectivBio Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sangamo Therapeutics and VectivBio Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sangamo Therapeutics and VectivBio Holding AG, you can compare the effects of market volatilities on Sangamo Therapeutics and VectivBio Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sangamo Therapeutics with a short position of VectivBio Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sangamo Therapeutics and VectivBio Holding.
Diversification Opportunities for Sangamo Therapeutics and VectivBio Holding
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sangamo and VectivBio is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Sangamo Therapeutics and VectivBio Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VectivBio Holding and Sangamo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sangamo Therapeutics are associated (or correlated) with VectivBio Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VectivBio Holding has no effect on the direction of Sangamo Therapeutics i.e., Sangamo Therapeutics and VectivBio Holding go up and down completely randomly.
Pair Corralation between Sangamo Therapeutics and VectivBio Holding
Given the investment horizon of 90 days Sangamo Therapeutics is expected to generate 3.12 times less return on investment than VectivBio Holding. In addition to that, Sangamo Therapeutics is 1.98 times more volatile than VectivBio Holding AG. It trades about 0.02 of its total potential returns per unit of risk. VectivBio Holding AG is currently generating about 0.14 per unit of volatility. If you would invest 822.00 in VectivBio Holding AG on August 23, 2024 and sell it today you would earn a total of 863.00 from holding VectivBio Holding AG or generate 104.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 30.44% |
| Values | Daily Returns |
Sangamo Therapeutics vs. VectivBio Holding AG
Performance |
| Timeline |
| Sangamo Therapeutics |
| VectivBio Holding |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Sangamo Therapeutics and VectivBio Holding Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sangamo Therapeutics and VectivBio Holding
The main advantage of trading using opposite Sangamo Therapeutics and VectivBio Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sangamo Therapeutics position performs unexpectedly, VectivBio Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VectivBio Holding will offset losses from the drop in VectivBio Holding's long position.| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
| VectivBio Holding vs. Cns Pharmaceuticals | VectivBio Holding vs. ZyVersa Therapeutics | VectivBio Holding vs. Immix Biopharma | VectivBio Holding vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |